• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-216b的过表达通过靶向c-Jun使非小细胞肺癌细胞对顺铂诱导的凋亡敏感。

Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun.

作者信息

Huang Gang, Pan Jiongwei, Ye Zaiting, Fang Bingmu, Cheng Wei, Cao Zhuo

机构信息

Department of Traditional Chinese Medicine, The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui People's Hospital, Lishui, 323000, China.

Department of Respiratory, The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui People's Hospital, Lishui, 323000, China.

出版信息

Oncotarget. 2017 Oct 27;8(61):104206-104215. doi: 10.18632/oncotarget.22171. eCollection 2017 Nov 28.

DOI:10.18632/oncotarget.22171
PMID:29262633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5732799/
Abstract

Platinum-based chemotherapy is still be the standard treatment for non-small cell lung cancer (NSCLC). Recently, studies demonstrate that some kinds of microRNAs (miRNAs) are associated with chemosensitivity of NSCLC cells to platinum-based treatment. Unfortunately, cancer cells usually change their expression profile of miRNAs to form drug resistance against chemotherapy. In the present study, we focused on miR-216b to investigate whether miR-216b determined sensitivity of NSCLC cells to cisplatin. We observed that expression level of miR-216b was significantly decreased in NSCLC cell lines when they were under the cisplatin treatment. However, restore of miR-216b by transfecting with its mimics was found to increase the cytotoxicity of cisplatin to NSCLC cells. Studies on mechanisms elucidated that miR-216b targeted c-Jun in NSCLC. Overexpression of miR-216b can suppress the cisplatin-induced upregulation of c-Jun. As the downstream, overexpression of Bcl-xl induced by c-Jun/ATF2 heterodimers was inhibited in miR-216b transfected NSCLC cells. Since Bcl-xl is a key anti-apoptotic protein, we found that sensitivity of NSCLC cells to cisplatin-induced apoptosis was significantly increased because of the overexpression of miR-216b.

摘要

铂类化疗仍然是治疗非小细胞肺癌(NSCLC)的标准方法。最近,研究表明某些种类的微小RNA(miRNA)与NSCLC细胞对铂类治疗的化疗敏感性相关。不幸的是,癌细胞通常会改变其miRNA的表达谱以形成对化疗的耐药性。在本研究中,我们聚焦于miR-216b来探究其是否决定NSCLC细胞对顺铂的敏感性。我们观察到,当NSCLC细胞系接受顺铂处理时,miR-216b的表达水平显著降低。然而,通过转染其模拟物来恢复miR-216b的表达,发现可增加顺铂对NSCLC细胞的细胞毒性。对机制的研究阐明,在NSCLC中miR-216b靶向c-Jun。miR-216b的过表达可抑制顺铂诱导的c-Jun上调。作为下游效应,在转染了miR-216b的NSCLC细胞中,由c-Jun/ATF2异二聚体诱导的Bcl-xl过表达受到抑制。由于Bcl-xl是一种关键的抗凋亡蛋白,我们发现miR-216b的过表达显著增加了NSCLC细胞对顺铂诱导凋亡的敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba0/5732799/d6bb4d351f93/oncotarget-08-104206-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba0/5732799/0c86b86ac612/oncotarget-08-104206-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba0/5732799/c82654d4b181/oncotarget-08-104206-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba0/5732799/bc48ad934dae/oncotarget-08-104206-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba0/5732799/8f5ae49cca1c/oncotarget-08-104206-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba0/5732799/2616ba2b81d4/oncotarget-08-104206-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba0/5732799/d6bb4d351f93/oncotarget-08-104206-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba0/5732799/0c86b86ac612/oncotarget-08-104206-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba0/5732799/c82654d4b181/oncotarget-08-104206-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba0/5732799/bc48ad934dae/oncotarget-08-104206-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba0/5732799/8f5ae49cca1c/oncotarget-08-104206-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba0/5732799/2616ba2b81d4/oncotarget-08-104206-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bba0/5732799/d6bb4d351f93/oncotarget-08-104206-g006.jpg

相似文献

1
Overexpression of miR-216b sensitizes NSCLC cells to cisplatin-induced apoptosis by targeting c-Jun.miR-216b的过表达通过靶向c-Jun使非小细胞肺癌细胞对顺铂诱导的凋亡敏感。
Oncotarget. 2017 Oct 27;8(61):104206-104215. doi: 10.18632/oncotarget.22171. eCollection 2017 Nov 28.
2
MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1.miR-216b 通过靶向 PARP1 增加卵巢癌细胞对顺铂的敏感性。
Cancer Gene Ther. 2017 May;24(5):208-214. doi: 10.1038/cgt.2017.6. Epub 2017 Mar 10.
3
Overexpression of miR-26b decreases the cisplatin-resistance in laryngeal cancer by targeting ATF2.miR-26b的过表达通过靶向ATF2降低喉癌的顺铂耐药性。
Oncotarget. 2017 Sep 8;8(45):79023-79033. doi: 10.18632/oncotarget.20784. eCollection 2017 Oct 3.
4
MicroRNA-216b regulated proliferation and invasion of non-small cell lung cancer by targeting SOX9.微小RNA-216b通过靶向SOX9调控非小细胞肺癌的增殖和侵袭。
Oncol Lett. 2018 Jun;15(6):10077-10083. doi: 10.3892/ol.2018.8573. Epub 2018 Apr 25.
5
MicroRNA-216b inhibits heat stress-induced cell apoptosis by targeting Fas in bovine mammary epithelial cells.微小 RNA-216b 通过靶向 Fas 抑制热应激诱导的奶牛乳腺上皮细胞凋亡。
Cell Stress Chaperones. 2018 Sep;23(5):921-931. doi: 10.1007/s12192-018-0899-9. Epub 2018 May 5.
6
MiR-216b/Smad3/BCL-2 Axis Is Involved in Smoking-Mediated Drug Resistance in Non-Small Cell Lung Cancer.微小RNA-216b/信号转导和转录激活因子3/凋亡抑制蛋白2轴参与非小细胞肺癌吸烟介导的耐药性
Cancers (Basel). 2020 Jul 13;12(7):1879. doi: 10.3390/cancers12071879.
7
Regulation of the P2X7R by microRNA-216b in human breast cancer.微小RNA-216b对人乳腺癌中P2X7受体的调控
Biochem Biophys Res Commun. 2014 Sep 12;452(1):197-204. doi: 10.1016/j.bbrc.2014.07.101. Epub 2014 Jul 28.
8
MicroRNA-218 regulates cisplatin (DPP) chemosensitivity in non-small cell lung cancer by targeting RUNX2.微小RNA-218通过靶向RUNX2调节非小细胞肺癌对顺铂(DPP)的化疗敏感性。
Tumour Biol. 2016 Jan;37(1):1197-204. doi: 10.1007/s13277-015-3831-2. Epub 2015 Aug 18.
9
miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8.微小RNA-107通过靶向细胞周期蛋白依赖性激酶8来调节A549非小细胞肺癌细胞系对顺铂的化疗敏感性。
Int J Clin Exp Pathol. 2014 Sep 15;7(10):7236-41. eCollection 2014.
10
miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.微小RNA-181c通过靶向Wnt抑制因子1促进非小细胞肺癌细胞对顺铂的耐药性。
Cancer Chemother Pharmacol. 2017 Nov;80(5):973-984. doi: 10.1007/s00280-017-3435-1. Epub 2017 Sep 27.

引用本文的文献

1
MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin.MicroRNAs 作为预测肺癌对顺铂耐药和敏感的标志物。
Int J Mol Sci. 2022 Jul 8;23(14):7594. doi: 10.3390/ijms23147594.
2
Blume Induces Apoptosis Against Acute Myeloid Leukemia Cells Regulation of the miR-216b/c-Jun.布鲁姆诱导急性髓系白血病细胞凋亡:miR-216b/c-Jun的调控
Front Oncol. 2022 Mar 9;12:808174. doi: 10.3389/fonc.2022.808174. eCollection 2022.
3
miR-129-2 upregulation induces apoptosis and promotes NSCLC chemosensitivity by targeting SOX4.

本文引用的文献

1
miR-216b inhibits glioma cell migration and invasion through suppression of FoxM1.微小RNA-216b通过抑制叉头框蛋白M1来抑制胶质瘤细胞的迁移和侵袭。
Oncol Rep. 2017 Sep;38(3):1751-1759. doi: 10.3892/or.2017.5824. Epub 2017 Jul 17.
2
Knockdown of miR-27a sensitizes colorectal cancer stem cells to TRAIL by promoting the formation of Apaf-1-caspase-9 complex.通过促进凋亡蛋白酶激活因子-1-半胱天冬酶-9复合物的形成,敲低miR-27a可使结直肠癌干细胞对肿瘤坏死因子相关凋亡诱导配体(TRAIL)敏感。
Oncotarget. 2017 Jul 11;8(28):45213-45223. doi: 10.18632/oncotarget.16779.
3
MiR-216b increases cisplatin sensitivity in ovarian cancer cells by targeting PARP1.
miR-129-2 上调通过靶向 SOX4 诱导凋亡并增强 NSCLC 化疗敏感性。
Thorac Cancer. 2022 Apr;13(7):956-964. doi: 10.1111/1759-7714.14336. Epub 2022 Feb 11.
4
Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs.COVID-19 病理生理学中的细胞因子风暴:miRNAs 可能出现的功能紊乱。
Int Immunopharmacol. 2021 Dec;101(Pt A):108172. doi: 10.1016/j.intimp.2021.108172. Epub 2021 Sep 21.
5
miR‑383 increases the cisplatin sensitivity of lung adenocarcinoma cells through inhibition of the RBM24‑mediated NF‑κB signaling pathway.miR-383 通过抑制 RBM24 介导的 NF-κB 信号通路增加肺腺癌细胞对顺铂的敏感性。
Int J Oncol. 2021 Nov;59(5). doi: 10.3892/ijo.2021.5267. Epub 2021 Sep 24.
6
The expression of miRNA-216b is negatively correlated with 18F-FDG uptake in non-small cell lung cancer.miRNA-216b 的表达与非小细胞肺癌 18F-FDG 摄取呈负相关。
World J Surg Oncol. 2021 Sep 1;19(1):262. doi: 10.1186/s12957-021-02376-2.
7
MicroRNA-216b targets to potentiate autophagy and apoptosis of breast cancer cells the mTOR signaling pathway.微小RNA-216b靶向作用于mTOR信号通路,以增强乳腺癌细胞的自噬和凋亡。
Int J Biol Sci. 2021 Jul 13;17(11):2970-2983. doi: 10.7150/ijbs.48933. eCollection 2021.
8
microRNA-216b enhances cisplatin-induced apoptosis in osteosarcoma MG63 and SaOS-2 cells by binding to JMJD2C and regulating the HIF1α/HES1 signaling axis.miRNA-216b 通过与 JMJD2C 结合并调控 HIF1α/HES1 信号轴增强骨肉瘤 MG63 和 SaOS-2 细胞对顺铂的凋亡作用。
J Exp Clin Cancer Res. 2020 Sep 24;39(1):201. doi: 10.1186/s13046-020-01670-3.
9
The Role of Non-Coding RNAs as Prognostic Factor, Predictor of Drug Response or Resistance and Pharmacological Targets, in the Cutaneous Squamous Cell Carcinoma.非编码RNA在皮肤鳞状细胞癌中作为预后因素、药物反应或耐药性预测指标以及药理学靶点的作用
Cancers (Basel). 2020 Sep 8;12(9):2552. doi: 10.3390/cancers12092552.
10
Inhibition of TRIM32 Induced by miR-519d Increases the Sensitivity of Colorectal Cancer Cells to Cisplatin.miR-519d诱导的TRIM32抑制增强结直肠癌细胞对顺铂的敏感性。
Onco Targets Ther. 2020 Jan 10;13:277-289. doi: 10.2147/OTT.S235940. eCollection 2020.
miR-216b 通过靶向 PARP1 增加卵巢癌细胞对顺铂的敏感性。
Cancer Gene Ther. 2017 May;24(5):208-214. doi: 10.1038/cgt.2017.6. Epub 2017 Mar 10.
4
microRNA-216b inhibits cell proliferation and migration in human melanoma by targeting FOXM1 in vitro and in vivo.微小RNA-216b通过在体外和体内靶向叉头框蛋白M1抑制人黑色素瘤细胞的增殖和迁移。
Cell Biol Int. 2017 Dec;41(12):1272-1282. doi: 10.1002/cbin.10754. Epub 2017 Sep 10.
5
Direct regulation of FOXK1 by C-jun promotes proliferation, invasion and metastasis in gastric cancer cells.C-jun对FOXK1的直接调控促进胃癌细胞的增殖、侵袭和转移。
Cell Death Dis. 2016 Nov 24;7(11):e2480. doi: 10.1038/cddis.2016.225.
6
Knockdown of OCT4 may sensitize NSCLC cells to cisplatin.敲低OCT4可能会使非小细胞肺癌细胞对顺铂敏感。
Clin Transl Oncol. 2017 May;19(5):587-592. doi: 10.1007/s12094-016-1569-y. Epub 2016 Nov 10.
7
miR-216b suppresses breast cancer growth and metastasis by targeting SDCBP.微小RNA-216b通过靶向SDCBP抑制乳腺癌的生长和转移。
Biochem Biophys Res Commun. 2017 Jan 1;482(1):126-133. doi: 10.1016/j.bbrc.2016.10.003. Epub 2016 Oct 5.
8
MiR-128 reverses the gefitinib resistance of the lung cancer stem cells by inhibiting the c-met/PI3K/AKT pathway.微小RNA-128通过抑制c-甲硫氨酸/磷脂酰肌醇-3-激酶/蛋白激酶B通路逆转肺癌干细胞的吉非替尼耐药性。
Oncotarget. 2016 Nov 8;7(45):73188-73199. doi: 10.18632/oncotarget.12283.
9
The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy.HIF-2α-MALAT1-miR-216b轴通过调节自噬来调控肝癌细胞的多药耐药性。
Biochem Biophys Res Commun. 2016 Sep 23;478(3):1067-73. doi: 10.1016/j.bbrc.2016.08.065. Epub 2016 Aug 11.
10
MicroRNA-216b is downregulated in hepatocellular carcinoma and inhibits HepG2 cell growth by targeting Forkhead box protein M1.微小RNA-216b在肝细胞癌中表达下调,并通过靶向叉头框蛋白M1抑制HepG2细胞生长。
Eur Rev Med Pharmacol Sci. 2016 Jun;20(12):2541-50.